What stocks does SBI HEALTHCARE OPPORTUNITIES FUND hold?

SBI HEALTHCARE OPPORTUNITIES FUND holds a portfolio of Indian equity stocks disclosed monthly by SBI Mutual Fund to AMFI. The complete current holdings with weights and month-over-month changes are available on this page. Data is sourced from official AMFI portfolio disclosures.

Which AMC manages SBI HEALTHCARE OPPORTUNITIES FUND?

SBI HEALTHCARE OPPORTUNITIES FUND is managed by SBI Mutual Fund, a SEBI-registered Asset Management Company in India.

What category is SBI HEALTHCARE OPPORTUNITIES FUND?

SBI HEALTHCARE OPPORTUNITIES FUND is classified as a Equity mutual fund under SEBI's mutual fund categorisation framework.

How often is SBI HEALTHCARE OPPORTUNITIES FUND portfolio data updated?

Portfolio holdings for SBI HEALTHCARE OPPORTUNITIES FUND are updated monthly. SEBI mandates all AMCs to disclose their complete portfolio within 10 days of each month end. RightAdvise sources this data directly from official AMFI portfolio disclosures.

← SBI Mutual Fund

SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH

Equity Data as of Apr 2026 Comparing Mar 2026 → Apr 2026

Share: WhatsApp X

Stocks Held

Apr 2026

Equity Holdings

₹4,092.82 Cr

Equity only, excl. debt & cash

Top 5 Weight

34.4%

Moderate

Top 10 Weight

52.4%

Moderate

Changes

0 new · 2 exits

Top Sector

Pharmaceuticals & Biotechnology

64.4% of portfolio

📋 What Happened This Month SBI HEALTHCARE OPPORTUNITIES FUND exited 2 stocks from its portfolio this month. Vijaya Diagnostic Centre Limited was the biggest exit (Healthcare Services), which was held at 0.53%. Among existing holdings, Aurobindo Pharma Limited saw the biggest increase — now at 3.21% of the portfolio. Abbott India Limited was trimmed the most, now at 1.47%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 64.4%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.

NAV Performance

1 year history · SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH

+1.56%

+7.85%

+7.90%

+10.67%

Latest NAV

₹532.86

04 Jun 2026

52W High

₹543.54

-2% from High

52W Low

₹436.68

+22% from Low

Calendar Year Returns

Jan 1 to Dec 31 each year. Simple point-to-point — not CAGR.

2025

-2.5%

2024

+43.8%

2023

+39.7%

2022

-5.0%

2021

+21.5%

2020

+67.7%

2019

+0.5%

2018

-8.8%

2017

+3.3%

Rolling Returns

Performance across every possible investment start date.

1Y Rolling Avg

16.8%

+ve in 65% windows

86.5% / -18.1%

3Y Rolling Avg

17.7% p.a.

+ve in 85% windows

32.2% / -9.6%

5Y Rolling Avg

18.8% p.a.

+ve in 100% windows

34.0% / 6.9%

Crisis Period Behaviour

"Pre-inception" = fund didn't exist during that period.

2024–25 Tariff

-13.5%

Rec: Jul 2025 (7 mo)

COVID-19 Crash

-22.7%

Rec: Apr 2020 (1 mo)

2022 Rate Hike

-16.0%

Rec: May 2023 (1yr 4mo)

2018 IL&FS

-14.4%

Rec: Apr 2020 (2yr 1mo)

Risk Ratios

3 years daily NAV · Risk-free rate 6.5% p.a. What do these mean? →

Sharpe Ratio (3Y)

1.61

Return per unit of risk. >1 is good.

Sortino Ratio (3Y)

2.35

Penalises downside volatility only.

Std Deviation (3Y)

12.8%

Lower = more consistent returns.

NAV Chart ₹532.86 04 Jun 2026

Simple Moving Avg: Click to draw · click again to remove

SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH

Chart shows indexed performance (base = 100). Actual NAV: ₹532.86

Sector Shift Industry allocation month-over-month

Feb 2026 → Mar 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	62.9%	64.8%	▲ +2.0%
Healthcare Services	25.2%	24.5%	▼ -0.7%
Chemicals & Petrochemicals	3.3%	3.6%	▲ +0.3%
Healthcare Equipment & Supplies	2.0%	1.9%	● -0.1%
Retailing	0.6%	0.4%	▼ -0.2%

Mar 2026 → Apr 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	64.8%	64.4%	▼ -0.5%
Healthcare Services	24.5%	24.4%	● -0.1%
Chemicals & Petrochemicals	3.6%	3.4%	▼ -0.2%
Healthcare Equipment & Supplies	1.9%	2.2%	▲ +0.4%
Retailing	0.4%	0.3%	▼ -0.1%

🔴

Biggest Exit

Vijaya Diagnostic Centre Limited

0.53% was held · Healthcare Services

↑

Biggest Add

Aurobindo Pharma Limited

+0.64% · now 3.21%

↓

Biggest Trim

Abbott India Limited

-0.44% · now 1.47%

👋 Other funds also exited

Corona Remedies Limited 1 fund

What Changed?

Comparing Mar 2026 → Apr 2026

Mar 2026 → Apr 2026

🔴 2 Exits ↑ 14 Increased ↓ 17 Decreased

#	Stock	Sector	Last Weight (Mar 2026)
1	Vijaya Diagnostic Centre Limited ₹21.54 Cr	Healthcare Services	0.53%
2	Corona Remedies Limited ₹11.67 Cr	Pharmaceuticals & Biotechnology	0.29%

#	Stock	Sector	Mar 2026	Apr 2026	Change
1	Aurobindo Pharma Limited ₹138.95 Cr	Pharmaceuticals & Biotechnology	2.57%	3.21%	+0.64%
2	Rainbow Childrens Medicare Limited ₹37.57 Cr	Healthcare Services	0.35%	0.87%	+0.52%
3	Poly Medicure Limited ₹96.77 Cr	Healthcare Equipment & Supplies	1.88%	2.24%	+0.36%
4	Anthem Biosciences Limited ₹149.17 Cr	Pharmaceuticals & Biotechnology	3.17%	3.45%	+0.28%
5	Fortis Healthcare Limited ₹138.44 Cr	Healthcare Services	2.93%	3.20%	+0.27%
6	Sudeep Pharma Limited ₹96.23 Cr	Pharmaceuticals & Biotechnology	1.98%	2.23%	+0.25%
7	Sai Life Sciences Limited ₹106.95 Cr	Pharmaceuticals & Biotechnology	2.24%	2.47%	+0.23%
8	Cohance Lifesciences Limited ₹48.33 Cr	Pharmaceuticals & Biotechnology	0.89%	1.12%	+0.23%
9	Max Healthcare Institute Limited ₹223.44 Cr	Healthcare Services	4.97%	5.17%	+0.20%
10	Divi's Laboratories Limited ₹292.61 Cr	Pharmaceuticals & Biotechnology	6.59%	6.77%	+0.18%
11	Mankind Pharma Limited ₹143.79 Cr	Pharmaceuticals & Biotechnology	3.16%	3.33%	+0.17%
12	Laurus Labs Limited ₹132.11 Cr	Pharmaceuticals & Biotechnology	2.93%	3.06%	+0.13%
13	Concord Biotech Limited ₹82.22 Cr	Pharmaceuticals & Biotechnology	1.80%	1.90%	+0.10%
14	Krishna Institute Of Medical Sciences Limited ₹106.67 Cr	Healthcare Services	2.45%	2.47%	+0.02%

#	Stock	Sector	Mar 2026	Apr 2026	Change
1	Abbott India Limited ₹63.59 Cr	Pharmaceuticals & Biotechnology	1.91%	1.47%	-0.44%
2	Sun Pharmaceutical Industries Limited ₹506.32 Cr	Pharmaceuticals & Biotechnology	12.11%	11.71%	-0.40%
3	Jupiter Life Line Hospitals Ltd ₹110.33 Cr	Healthcare Services	2.84%	2.55%	-0.29%
4	Acutaas Chemicals Ltd ₹233.47 Cr	Pharmaceuticals & Biotechnology	5.67%	5.40%	-0.27%
5	Lupin Limited ₹165.97 Cr	Pharmaceuticals & Biotechnology	4.10%	3.84%	-0.26%
6	Torrent Pharmaceuticals Limited ₹150.66 Cr	Pharmaceuticals & Biotechnology	3.74%	3.48%	-0.26%
7	Aether Industries Limited ₹144.74 Cr	Chemicals & Petrochemicals	3.56%	3.35%	-0.21%
8	Biocon Limited ₹134.87 Cr	Pharmaceuticals & Biotechnology	3.33%	3.12%	-0.21%
9	SANOFI CONSUMER HEALTHCARE ₹19.06 Cr	Pharmaceuticals & Biotechnology	0.63%	0.44%	-0.19%
10	Apollo Hospitals Enterprise Limited ₹229.10 Cr	Healthcare Services	5.48%	5.30%	-0.18%
11	Alkem Laboratories Limited ₹108.00 Cr	Pharmaceuticals & Biotechnology	2.61%	2.50%	-0.11%
12	Ajanta Pharma Limited ₹84.68 Cr	Pharmaceuticals & Biotechnology	2.07%	1.96%	-0.11%
13	MedPlus Health Services Limited ₹13.08 Cr	Retailing	0.41%	0.30%	-0.11%
14	Gufic Biosciences Ltd. ₹20.06 Cr	Pharmaceuticals & Biotechnology	0.54%	0.46%	-0.08%
15	Aster DM Healthcare Limited ₹168.25 Cr	Healthcare Services	3.96%	3.89%	-0.07%
16	Gland Pharma Limited ₹105.05 Cr	Pharmaceuticals & Biotechnology	2.50%	2.43%	-0.07%
17	Nephrocare Health Services Ltd ₹42.34 Cr	Healthcare Services	1.00%	0.98%	-0.02%

Full Portfolio

31 stocks — Apr 2026

#	Stock	Sector	Weight & Value
1	Sun Pharmaceutical Industries Limited ₹506.32 Cr	Pharmaceuticals & Biotechnology	11.71%
2	Divi's Laboratories Limited ₹292.61 Cr	Pharmaceuticals & Biotechnology	6.77%
3	Acutaas Chemicals Ltd ₹233.47 Cr	Pharmaceuticals & Biotechnology	5.40%
4	Apollo Hospitals Enterprise Limited ₹229.10 Cr	Healthcare Services	5.30%
5	Max Healthcare Institute Limited ₹223.44 Cr	Healthcare Services	5.17%
6	Aster DM Healthcare Limited ₹168.25 Cr	Healthcare Services	3.89%
7	Lupin Limited ₹165.97 Cr	Pharmaceuticals & Biotechnology	3.84%
8	Torrent Pharmaceuticals Limited ₹150.66 Cr	Pharmaceuticals & Biotechnology	3.48%
9	Anthem Biosciences Limited ₹149.17 Cr	Pharmaceuticals & Biotechnology	3.45%
10	Aether Industries Limited ₹144.74 Cr	Chemicals & Petrochemicals	3.35%
11	Mankind Pharma Limited ₹143.79 Cr	Pharmaceuticals & Biotechnology	3.33%
12	Aurobindo Pharma Limited ₹138.95 Cr	Pharmaceuticals & Biotechnology	3.21%
13	Fortis Healthcare Limited ₹138.44 Cr	Healthcare Services	3.20%
14	Biocon Limited ₹134.87 Cr	Pharmaceuticals & Biotechnology	3.12%
15	Laurus Labs Limited ₹132.11 Cr	Pharmaceuticals & Biotechnology	3.06%
16	Jupiter Life Line Hospitals Ltd ₹110.33 Cr	Healthcare Services	2.55%
17	Alkem Laboratories Limited ₹108.00 Cr	Pharmaceuticals & Biotechnology	2.50%
18	Sai Life Sciences Limited ₹106.95 Cr	Pharmaceuticals & Biotechnology	2.47%
19	Krishna Institute Of Medical Sciences Limited ₹106.67 Cr	Healthcare Services	2.47%
20	Gland Pharma Limited ₹105.05 Cr	Pharmaceuticals & Biotechnology	2.43%
21	Poly Medicure Limited ₹96.77 Cr	Healthcare Equipment & Supplies	2.24%
22	Sudeep Pharma Limited ₹96.23 Cr	Pharmaceuticals & Biotechnology	2.23%
23	Ajanta Pharma Limited ₹84.68 Cr	Pharmaceuticals & Biotechnology	1.96%
24	Concord Biotech Limited ₹82.22 Cr	Pharmaceuticals & Biotechnology	1.90%
25	Abbott India Limited ₹63.59 Cr	Pharmaceuticals & Biotechnology	1.47%
26	Cohance Lifesciences Limited ₹48.33 Cr	Pharmaceuticals & Biotechnology	1.12%
27	Nephrocare Health Services Ltd ₹42.34 Cr	Healthcare Services	0.98%
28	Rainbow Childrens Medicare Limited ₹37.57 Cr	Healthcare Services	0.87%
29	Gufic Biosciences Ltd. ₹20.06 Cr	Pharmaceuticals & Biotechnology	0.46%
30	SANOFI CONSUMER HEALTHCARE ₹19.06 Cr	Pharmaceuticals & Biotechnology	0.44%
31	MedPlus Health Services Limited ₹13.08 Cr	Retailing	0.30%